483
Northern VA Compounders PLLCNorthern VA Compounders PLLC – FDA 483, Dec 9, 2022
Record Details
An FDA inspection of Northern VA Compounders PLLC in Sterling, VA, revealed significant deficiencies in both sterile and non-sterile drug production. Key issues included inadequate measures to prevent cross-contamination, the use of non-pharmaceutical grade components, and poor environmental controls within aseptic processing areas. These observations highlight a lack of adherence to proper manufacturing practices, potentially compromising drug product quality and patient safety.
View Company Profile
ID · 8049d036-6d82-4a10-be51-67268da56004
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.